BD Launches Unique System for Safe Transportation of Blood Culture Vials
BD BACTEC™ SafePod enables transportation of two vials at once
Oxford, UK (9 March 2011) – BD (Becton, Dickinson and Company), a leading global medical technology company, announced today the launch of the BD BACTEC™ SafePod, designed for the safe transportation of blood culture vials in pneumatic tube systems, and for safe transportation of positive blood cultures from satellite sites to a central laboratory.
Chris Head-Jenner, Marketing Manager, UK and Ireland, BD, who led the product design, says: “Historically, there has been a reluctance to transport biological compounds in glass bottles through hospital pneumatic tube systems, for fear of breakage. The BD BACTEC™ SafePod addresses these customer concerns by providing a system that safely transports biological compounds, meets HPA requirements, whilst also saving space and time.”
ImperialCollege Healthcare NHS Trustis now using the BD BACTEC™ SafePod system at St. Mary’s, Chelsea and Westminster, Hammersmith and Charing Cross Hospitals. Feedback from staff suggests that the new system is easy to load to use, and there have been no reports of breakage.
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com